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ABSTRACT: Acinetobacter species are gaining importance in the 
present days. Here we report isolation of 149 isolates of 
Acinetobacter species from various clinical samples from the 
intensive units of our hospital. We used standard microbiological 
techniques to identify the isolates and antibiotic sensitivity testing 
was done by using Kirby-Bauer disc diffusion technique. A.baumanii 
was the commonest organism in our study and was found multi drug 
resistant. 
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Introduction 
The identity of genus Acinetobacter ambiguous for many years and 
was earlier classified under different genera. The newer techniques 
resolved the confusion in identification and classification of these 
organisms.[1] These techniques include phenotypic and DNA-DNA 
hybridization techniques. But these techniques are cumbersome and 
time consuming. [2] These organisms were once considered as 
contaminants in clinical laboratories however, now they are 
considered as important nosocomial pathogens. They are known to 
cause different kinds of opportunistic infections.[2, 3] They are non 
fermentative aerobic gram negative rods, which are ubiquitous in 
nature and are also commonly found on the normal human flora.[4] 
These organisms have tremendous colonizing capability, especially in 
hospitalized patients. [5] 
The role of the newer pathogens has now been recognized 
especially in neonates and cancer patients and also in patients 
admitted in intensive units. [6, 7, 8, 9] This is because of the 
ubiquitous nature of the organisms and their colonizing capacity on 
diagnostic and therapeutic ICU settings. [2] Despite of the 
increasing significance and frequency of multiple drug resistant 
Acinetobacter infections, many clinicians still lack an appreciation of 
the potential importance of these organisms in hospitals. The 
present study was undertaken to determine the prevalence of 
Acinetobacter species and their antibiotic sensitivity pattern in 
patients of our hospital. 
 
Material and Methods 
The present study was conducted in the Microbiology laboratory of 
our Hospital during the period of Jan – Dec 2005. A total of 6989 
clinical samples from patients admitted in the hospital were received 
for bacteriological study. The samples were processed as per the 
standard Microbiological methods. Non lactose fermenting colonies 
on Mac Conkey’s medium were tested for oxidase test, catalase and 
motility by hanging drop. The isolates which were oxidase negative, 
catalase positive and non motile were considered as Acinetobacter 
species and were further processed for species level identification 
(Table No 1). Antibiotic sensitivity of these isolates was performed 
by using Kirby Baeur disc diffusion method on Muller Hinton Agar.
 
 
Table No.1 showing the biochemical reactions used for identifying the Acinetobacter species 
 
 
 
 
 
 
 
 
 
 
Results  
From 6989 samples, 149 (2.13%) yielded Acinetobacter species. 
Table 2, summarizes the source of different clinical materials and 
Table No.3 shows the distribution of Acinetobacter isolates from 
patients admitted in different wards of the hospital. Of the 149 
Acinetobacter isolates, 68 (45.63%) were A. baumanii, 43 (28.85 %)   
A. calcoaceticus and 21 (14.09%) A.haemolyticus. Seventeen 
isoaltes could not be identified up to species level. 
The antibiotic sensitivity results revealed that, 87 (58.39%) of the 
isolates were resistant to Ciprofloxacin, Cefotaxime, Ofloxacin and 
Amikacin. Twenty (14.42%) isoaltes were resistant to Ceftazidime 
and Ciprofloxacin in combination and ten (6.71 %) to Ciprofloxacin 
and-Ofloxacin.
 
Table No.2. Number of samples showing isolation of Acinetobacter species 
 
 
 
 
 
 
 
 
 
 
 
 
 
Organisms Nitrate 
reduction  
Growth at Haemolysis -Blood 
agar. 
O/F of 10% 
glucose 
Arginine 
hydrolysis 
370 440
A.baumanii Negative Positive Positive Negative Positive Positive 
A.haemolyticus Negative Positive Negative Positive Variable Positive 
A.calcoaciticus. Negative Positive Negative Negative Positive Negative 
Sl. No. Samples. Number (%) 
1 Blood   37 (24.83) 
2 Pus 39 (26.17) 
3 ET tip 19 (12.75) 
4 Urine 18 ( 12.08) 
5 Central line tip 05 (3.35) 
6 Suction tip 05 (3.35) 
7 Cervical swab 05 (3.35) 
8 Tracheal secretions 03 (2.01) 
9 Eye swab 03 (2.01) 
10 others 15 (10.06) 
Total 149 
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Table: 3 Distribution of isolates in the  wards 
 
Sl. No Ward No (%) 
1 NICU 43 (28.85) 
2 MICU 29 (19.46) 
3 PICU 20 (13.42) 
4 Burns ward 15 (10.06) 
5 Gen Ward 13  (8.72) 
6 NSICU 08 (5.36) 
7 ITU 08 (5.36) 
8 SICU 08 (5.36) 
9 Paed ward  05 (3.35) 
Total 149 
 
 
Discussion 
The isolation of Acinetobacter species from clinical samples had less 
significance and were regarded as mere contaminants in the past 
and hence, further characterization was deemed unnecessary. [1, 
10] In the recent times it is known that these organisms can cause 
various clinical and nosocomial infections. [11] The isoaltes in the 
present study were from the patients admitted in intensive care 
units (ICU/PICU/SICU/MICU) suffering from various clinical 
infections. 
During the routine environmental surveillance cultures we did not 
isolate any Acinetobacter species from exposed Petri plates and no 
clustering of the cases were observed. This proves that probably 
organisms were not from hospital environment. However, Gulati S., 
et. al., isolated these organisms from hospital environment as well 
as from clinical samples. These authors have also proved them to be 
the nosocomial pathogens. [1]  
Prashant K et. al., have isolated 48.8% of Acinetobacter species 
from respiratory  infections, 16.27% from blood stream infections, 
9.3% from urine and the rest from other samples.[12] But in our 
study the major isolates are from pus (26.17%), blood (24.83%), 
respiratory samples (i.e. ET tip, Suction tip & Tracheal aspirations) 
(18.11%) and in urine (12.08%). This variation between the studies 
may be because of severity of patients admitted and also number of 
the samples received at our laboratory. A. baumanii was the most 
common clinical isolate in most of the studies and was reported to 
be associated with invasive infections and in immunosuppressive 
patients. [9,12,13] We have found that A.baumanii (45.63%) as a 
major isolate in our study. Seventeen isolates of our study could not 
be speciated, because of certain limitations as the methods we used 
and they have some inherited limitations. These isolates may be 
belonged to any of the species if we have used extensive 
biochemical tests or DNA-DNA hybridization methods. [1]    
With simple biochemical tests, we presumptively identified  and 
speciated Acinetobacter organisms by using hemolysis on blood 
agar, Nitrate reduction test, growth at 370 C and 440C acid 
production from glucose and arginine hydrolysis. As mentioned by 
Gulati S et. al., it may not be possible for every microbiology 
laboCratory to identify these organisms to genospecies level because 
these laboratories are not commonly carrying out molecular 
methods or extensive carbohydrate assimilation tests as a routine 
exercise. [1]   
In conclusion, A. baumanii was the commonest species responsible 
for majority of Acinetobacter in our hospital. Multi-drug resistant 
Acinetobacter species from high risk areas can cause severe life 
threatening infections despite of them not being present in such 
environments. If these organisms isolated from intensive units, 
microbiologist should report them as a pathogen and he/she should 
also monitor the routine environmental surveillance cultures in these 
areas to identify as these organisms are known to be present in 
hospital environment. 
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